SCHEMBL15328664

SCHEMBL15328664

Cc1cc(N2CCOCC2)cc(O)c1C(=O)NCc1ccc(F)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.52
ALDH1A1 P00352 2/20 0.52
TSHR P16473 1/20 0.52
PSMD14 O00487 1/20 0.49
TP53 P04637 2/20 0.49
KMT2A Q03164 2/20 0.48
NAMPT P43490 1/20 0.48
ERCC1 P07992 1/20 0.47
ERCC4 Q92889 1/20 0.47
LMNA P02545 3/20 0.47
THRB P10828 1/20 0.45
PPARG P37231 1/20 0.45
KCNQ3 O43525 1/20 0.44
KCNQ2 O43526 1/20 0.44
KLKB1 P03952 1/20 0.44
KLK1 P06870 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15328621 0.89 KMT2A (0.51) TP53KMT2AERCC1ERCC4LMNA
SCHEMBL15328957 0.87 LMNA (0.51) GAAALDH1A1TSHRPSMD14TP53
SCHEMBL15328287 0.87 GAA (0.49) GAAALDH1A1TSHRPSMD14TP53
SCHEMBL15328484 0.86 GAA (0.48) GAAALDH1A1TSHRPSMD14TP53
SCHEMBL15328663 0.86 TP53 (0.48) GAAALDH1A1TSHRPSMD14TP53
SCHEMBL15328467 0.81 ERCC1 (0.47) ALDH1A1TP53KMT2ANAMPTERCC1
SCHEMBL15328430 0.78 KMT2A (0.48) TP53KMT2ALMNATHRBPPARG
SCHEMBL15328501 0.78 KMT2A (0.50) TP53KMT2ALMNATHRBPPARG
SCHEMBL15328274 0.78 PPARG (0.48) TP53KMT2ALMNATHRBPPARG
SCHEMBL2130924 0.77 TP53 (0.48) GAAALDH1A1TSHRTP53KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US disclosed
EP-2844645-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-03-11 EP disclosed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US disclosed
WO-2013156155-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS KCNJ2, KCNQ2, KCNQ1 GAA 3329/4885ALDH1A1 3041/4885TSHR 4249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.